Cognetivity Neurosciences Enters Commercial Agreement With UK-Based Brain Health Supplements Provider
Cognetivity Neurosciences Enters Commercial Agreement With UK-Based Brain Health Supplements Provider
Agreement sees Cognetivity expand commercial offering into sports and fitness market, with cutting-edge assessment and monitoring technology made available to customers of brain health supplement subscription service
根據協定，Cognetivity將商業服務擴展到體育和健身市場，向大腦健康補充劑訂閱服務的客戶提供尖端的評估和監測技術
Vancouver, British Columbia--(Newsfile Corp. - March 15, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that it has reached a commercial agreement with brain health supplements provider Conka.
溫哥華，不列顛哥倫比亞省-(Newsfile Corp.-2023年3月15日)-認知神經科學有限公司(CSE：CGN)(OTCQB：CGNSF)(FSE：1UB)(“公司”或“認知”)，一家創建了用於醫療、商業和消費環境的獨特腦健康篩查平臺的科技公司高興地宣佈，它已與腦健康補充劑提供商Conka達成商業協定。
Conka is a UK-based provider of natural brain health supplements, geared towards individuals engaging in high-performance sports and other physical activities. Conka's mission is to enable its customers to unlock their potential in all areas of their lives by optimizing their cognition. The global dietary supplements market has experienced rapid growth since 2020 and is projected to grow from $71.81 billion in 2021 to $128.64 billion in 2028.
康佳是一家總部位於英國的天然腦健康補充劑供應商，面向從事高性能運動和其他體育活動的個人。康佳的使命是使其客戶能夠通過優化他們的認知來釋放他們在生活各個領域的潛力。自2020年以來，全球膳食補充劑市場經歷了快速增長，預計將從2021年的718.1億美元增長到2028年的1286.4億美元。
The new agreement between Cognetivity and Conka will see Cognetivity act as Conka's technology partner. Cognetivity's cutting-edge brain health assessment technology will be made available to Conka's customers so that they can sensitively and accurately measure changes in their cognitive performance, helping them to optimize their mental and physical state and to guard against the risks of head injuries and concussion.
根據Cognetivity和Conka之間的新協定，Cognetivity將成為Conka的技術合作夥伴。Cognetivity的尖端大腦健康評估技術將提供給康佳的客戶，使他們能夠敏感和準確地測量他們認知表現的變化，幫助他們優化自己的心理和身體狀態，並預防頭部受傷和腦震盪的風險。
Humphrey Bodington, Conka's Co-Founder and CEO said "Tracking speed and accuracy of decision making has been an important metric in our scientific trials. Including the test within our own app enables our consumers to have access to a trusted brain health assessment tool. This means CONKA can create a more impactful experience for our customers." He added "Our subscribers can not only feel the difference but objectively track improvements in brain performance, a critical level of awareness for anyone wanting to map how their lifestyle choices affect their cognitive status."
康佳聯合創始人兼首席執行官漢弗萊·博丁頓表示：“跟蹤決策的速度和準確性一直是我們科學試驗中的一項重要指標。在我們自己的應用程式中包括這項測試，使我們的消費者能夠獲得值得信賴的大腦健康評估工具。這意味著康佳可以為我們的客戶創造更有影響力的體驗。”他補充道：“我們的訂閱者不僅可以感受到不同之處，還可以客觀地跟蹤大腦表現的改善，對於任何想要繪製出他們的生活方式選擇如何影響他們的認知狀態的人來說，這是一個關鍵的意識水準。”
"We are thrilled with this new development," remarked Cognetivity's CEO, Dr. Sina Habibi. "While we are deeply committed to working alongside clinicians and patients to detect and treat brain health disorders like Alzheimer's and Multiple Sclerosis, this new use case highlights the tremendous potential of CognICA as a platform technology for enhancing brain wellness and performance. By focusing on prevention rather than just cure, we can make significant strides in improving both short-term and long-term health outcomes. We're excited to be leading the way in this critical area."
Cognetivity的首席執行官Sina Habibi博士說：“我們對這一新進展感到非常興奮。”雖然我們致力於與臨床醫生和患者合作，檢測和治療阿爾茨海默氏症和多發性硬化症等大腦健康疾病，但這一新的使用案例突顯了CognICA作為增強大腦健康和表現的平臺技術的巨大潛力。通過專注於預防而不僅僅是治療，我們可以在改善短期和長期健康結果方面取得重大進展。我們很高興能在這一關鍵領域走在前列。
About Cognetivity Neurosciences Ltd.
關於認知性神經科學有限公司
Cognetivity is a technology company that has created a cognitive testing platform for use in medical, commercial and consumer environments. Cognetivity's ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of cognitive impairment by testing the performance of large areas of the brain. The ICA is currently available for clinical use in the USA, UK, Europe and the Middle East, with regulatory approval for other regions planned for 2023.
Cognetivity是一家技術公司，它創建了一個認知測試平臺，用於醫療、商業和消費環境。Cognetivity的ICA使用人工智慧和機器學習技術，通過測試大腦大片區域的表現來幫助檢測認知障礙的最早跡象。ICA目前可在美國、英國、歐洲和中東用於臨床，其他地區的監管批准計劃於2023年進行。
ON BEHALF OF THE BOARD
我代表董事會
"Sina Habibi"
Sina Habibi
《新浪哈比比》
新浪哈比比
Chief Executive Officer and Director
董事首席執行官兼首席執行官
FORWARD-LOOKING STATEMENTS:
前瞻性陳述：
Certain statements included in this news release constitute forward-looking information or statements (collectively, "forward-looking statements"), including those identified by the expressions "anticipate", "assume" "believe", "plan", "estimate", "expect", "intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This news release contains forward looking statements. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Such statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company's forward-looking statements.
本新聞稿中包含的某些陳述構成前瞻性資訊或陳述(統稱為“前瞻性陳述”)，包括“預期”、“假設”、“相信”、“計劃”、“估計”、“預期”、“打算”、“可能”、“應該”以及與公司或其管理層有關的類似表述。前瞻性陳述不是歷史事實，但反映了對未來結果或事件的當前預期。本新聞稿包含前瞻性陳述。這些前瞻性陳述不是對未來業績的保證，涉及難以預測的風險、不確定因素和假設。此類陳述基於當前預期和各種估計、因素和假設，涉及已知和未知的風險、不確定性和其他因素。這些陳述和資訊是基於對目前和未來的業務戰略以及公司未來運營環境的許多假設。除非法律要求，否則公司不承擔更新或修改前瞻性資訊以反映新事件或新情況的責任。讀者不應過分依賴該公司的前瞻性陳述。
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
加拿大證券交易所不對本新聞稿的充分性或準確性承擔責任。
For further information: Please visit: or contact: info@cognetivity.com; for media inquiries please contact pr@cognetivity.com.
有關更多資訊，請訪問：請訪問：或聯繫：info@cognetivity.com；媒體查詢請聯繫pr@cognetivity.com。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。